Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
about
Multiscale prediction of patient-specific platelet function under flowSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksValidation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis.Gastroprotective agent underuse in high-risk older daily nonsteroidal anti-inflammatory drug users over timeRisk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular eventsThe postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissectionRisk of severe upper gastrointestinal complications among oral bisphosphonate usersOral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study.Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective.Standards of the Polish Ultrasound Society - update. Ultrasound examination of thyroid gland and ultrasound-guided thyroid biopsy.Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based settingGastrointestinal events with clopidogrel: a nationwide population-based cohort study.Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?Mechanistic and pharmacological issues of aspirin as an anticancer agent.Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease.Development and use of sulodexide in vascular diseases: implications for treatment.Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran.Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population.Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.Aspirin resistance and other aspirin-related concerns.Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.Antithrombotic therapy in aortic diseases: A narrative review.Review article: a practical approach to the clinical management of NSAID enteropathy.Severe hepatoxicity caused by aspirin overdose: a case report.Continuing use of antithrombotic medications for patients with bleeding gastroduodenal ulcer requiring endoscopic hemostasis: a case-control study.Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.The outcome and role of drugs in patients with unexplained gastrointestinal bleeding.Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionSteroid ulcers: Any news?The aspirin cardiovascular/gastrointestinal risk calculator--a tool to aid clinicians in practice.[Bleeding origin, patient-related risk factors, and prognostic indicators in patients with acute gastrointestinal hemorrhages requiring intensive care treatment. A retrospective analysis from 1999 to 2010].Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers.Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts.Represcription of low-dose acetylsalicylic acid after discontinuation in patients receiving treatment for secondary cardiovascular disease prevention in the UK.
P2860
Q30519534-97E35A30-49B2-4750-A76C-DF3BB18799EAQ30629677-5EB1BCDC-33E6-409F-AD46-EDCE87CA0B53Q31031802-0770626D-FA90-4DBC-B3AE-5CDAC6E3FDD3Q33864188-0CD64A6C-7BBB-400F-82CD-F12BE6C6DD81Q34389027-46C454BE-84AA-43BF-AB56-3263FC004B0BQ34746758-04BB0935-187D-4AE7-83F6-3BD70C3CC131Q34980127-E311877F-B98B-4587-A2F0-A953FD53E587Q35069355-0B036FBC-1C6E-4429-8AA2-30F78CFBDE2AQ35084489-26688872-FDCB-4003-9DF0-01115788A705Q35181596-C0F61E96-16E0-47C9-8D45-5C48949F01A8Q36085212-EE2AA63F-903D-4B9C-996B-AE33A83C061FQ36094923-F0C72E10-2C10-4514-BBF8-8D22C8AA906DQ36117689-DBAA5D0B-0BF8-4DEB-8061-DEB25C83ABD6Q36733540-17E77D48-19DD-40B2-9497-812C4F7F091CQ36734102-368974CE-9F53-4FBA-BA60-A08CB3384608Q36942298-8654F0FD-1DFA-48EC-B8FD-3B70942AB326Q37277350-C04ED3C7-4F62-47E8-A758-C24C50586AB0Q37300872-A6AE0AA5-5003-43C1-9264-473D849F60DDQ37427653-8241F18B-E552-4278-905C-6D55AF288B7AQ37743623-E0EEB7BE-3F42-487E-A638-F20780639056Q38041462-EB67ED59-E1BB-454A-9DF2-BF7A9D107FD5Q38114868-8D8A3C1A-68C3-4931-8515-5B9B995DDFA7Q38271121-07585FC3-FB91-4205-BB11-7CB993E60900Q38362344-6D5820D6-FEF5-4A48-96C0-8D257BABA181Q38634815-06410B2C-7D35-46CC-A096-61850BD0CC43Q38809179-ADB9A6D6-D5FD-47E5-8432-0871DDB4C87FQ39142382-EEE7F950-AB84-48D4-8907-D96CBB44988BQ39354761-458421A4-F79E-4290-AD0A-C4395A472768Q40151091-928513D9-5333-4D90-80E9-2FD5004DE643Q40203391-038DB96E-8CDD-49BB-AAC0-52AD65B94CB0Q40248473-23EFF3CF-E9EA-4A2B-8C0B-3C1C020D1F51Q40823644-8202896A-8732-4489-8BD5-5C84311FD24FQ42219817-EF82C545-D59D-486B-BF7C-569A0D35FCBBQ42371575-982CB97F-C47D-438D-8A82-C89938EE6A1BQ43065903-69D437AB-50D6-4A44-92EC-145A7B59B04AQ43493427-7C6997A5-7AC0-4898-8342-CEB734A33ED6Q44162046-DC652FA8-CD41-4107-B277-E1C687D657E5Q44375151-D4C65CEC-B602-40E3-85E5-CA3E3BA628F0Q44847410-9816BE76-8554-401B-BD67-793A0969249BQ45792413-72684559-6399-4113-9D3C-D912B472BA0F
P2860
Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Risk of upper gastrointestinal ...... idogrel and other medications.
@en
type
label
Risk of upper gastrointestinal ...... idogrel and other medications.
@en
prefLabel
Risk of upper gastrointestinal ...... idogrel and other medications.
@en
P2093
P1433
P1476
Risk of upper gastrointestinal ...... idogrel and other medications.
@en
P2093
Kueiyu Joshua Lin
Luis A García Rodríguez
Saga Johansson
Sonia Hernández-Díaz
P304
P356
10.1161/CIRCULATIONAHA.110.973008
P407
P577
2011-02-28T00:00:00Z